Scarica l'app Stockscreener
55.45
16.57%
7.88
Pre-mercato:
52.75
-2.70
-4.87%
Qiagen Nv Borsa (QGEN) Ultime notizie
QIAGEN NV : Buy rating from Jefferies - marketscreener.com
Middle East Exosomes Market Research Report 2025-2033: Diagnostic and Therapeutic Adoption, R&D Investment, and Liquid Biopsy Demand Drive Growth - GlobeNewswire Inc.
Qiagen Said to Weigh Strategic Options Amid Fresh Interest - Bloomberg
Qiagen (QGEN) Hits 4-Year High as Earnings Loom - Insider Monkey
Qiagen (NYSE:QGEN) Sets New 52-Week HighStill a Buy? - MarketBeat
Qiagen (QGEN) Shares Surge Amid Takeover Speculation - GuruFocus
Agilent and Danaher Eye Qiagen Acquisition as Shares Surge 19% - Intellectia AI
Agilent, Danaher could be potential buyers of Qiagenanalyst (QGEN:NYSE) - Seeking Alpha
Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk - TechStock²
Qiagen gains on report it's weighing options amid takeover interest - MSN
Dutch biotech company soars: Rumors of discussions with potential buyers - medwatch.com
Qiagen (QGEN) Surges 12% Amid Potential Sale Discussions - GuruFocus
Qiagen (QGEN) Evaluates Sale Options Amid Takeover Interest, Shares Up 12% - Intellectia AI
Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports - Reuters
QIAGEN Stock Poised for Movement Amid Q4 Results Announcement - StocksToTrade
QGEN Stock Rises Amid Potential Sale Discussions - GuruFocus
Qiagen stock soars after report company weighing strategic options By Investing.com - Investing.com Nigeria
Qiagen stock soars after report company weighing strategic options - Investing.com
Qiagen Is Said to Consider Strategic Options Amid Fresh Interest - Bloomberg.com
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast - sharewise.com
How to listen to QIAGEN’s Q4 2025 earnings webcast on Feb. 5 - Stock Titan
23,093 Shares in Qiagen N.V. $QGEN Purchased by SG Americas Securities LLC - MarketBeat
Qiagen N.V. $QGEN Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Sumitomo Mitsui Trust Group Inc. Invests $7.29 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Short Interest Down 20.2% in December - MarketBeat
Campbell & CO Investment Adviser LLC Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
Analysis Recap: Is Qiagen NV stock a smart retirement pickJuly 2025 Earnings & Safe Capital Investment Plans - baoquankhu1.vn
Qiagen Reports AFM Notification of Major Stake by Massachusetts Financial Services - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
QIAGEN NV : Receives a Buy rating from DZ Bank - marketscreener.com
Qiagen N.V.: How a Quiet Diagnostics Powerhouse Became a Platform Bet on the Future of Medicine - AD HOC NEWS
Qiagen and Gencurix partner for oncology tests - MSN
Did Qiagen’s (QGEN) AI and Automation Push Just Redefine Its Diagnostics Investment Narrative? - simplywall.st
JPM26: Qiagen outlines key priorities to drive momentum in 2026 - Medical Device Network
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More - GlobeNewswire
Aug Momentum: How Qiagen NV stock performs in interest rate cycles2025 Big Picture & High Accuracy Swing Entry Alerts - Bộ Nội Vụ
QIAGEN Board Member’s Holdings Adjusted Following Share Consolidation - TipRanks
QIAGEN Adjusts Management Shareholdings Following Synthetic Share Repurchase - TipRanks
QIAGEN Adjusts Board Member Shareholding Following Synthetic Share Consolidation - TipRanks
QIAGEN discloses management share consolidation under synthetic repurchase program - TipRanks
QIAGEN adjusts insider shareholdings after synthetic share repurchase and consolidation - TipRanks
QIAGEN adjusts board member shareholding after synthetic share consolidation - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView — Track All Markets
Qiagen N.V.: Diagnostics Specialist Tests Investor Patience Amid Sideways Trading and Selective Opti - AD HOC NEWS
Qiagen (QGEN) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth - BioSpace
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Soli - PharmiWeb.com
Qiagen sets 2026 priorities to drive growth - marketscreener.com
Qiagen N.V.: How a Quiet Diagnostics Powerhouse Became a Genomics Infrastructure Play - AD HOC NEWS
Published on: 2026-01-10 23:18:15 - ulpravda.ru
Qiagen (NYSE:QGEN) Stock Rating Lowered by Wall Street Zen - MarketBeat
Qiagen N.V.: How a Quiet Workflow Powerhouse Is Shaping the Future of Molecular Diagnostics - AD HOC NEWS
Qiagen N : announces adjustment of conversion price under its US$ 500,000,000 Convertible Bonds due 2031 - marketscreener.com
Qiagen N : announces adjustment of conversion price under its US$ 500,000,000 Convertible Bonds due 2027 - marketscreener.com
Will Qiagen N.V. stock recover faster than peersStock Surge & Low Risk Profit Maximizing Plans - Улправда
3.90%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):